April 06, 2017
A federal judge in Boston said Thursday that he would allow Momenta and Sandoz to move again for dismissal in an antitrust dispute with Amphastar over a generic blood-clotting drug, and, depending on how that goes, eyed a tentative trial date two years from now.
July 27, 2016
A Massachusetts federal judge on Wednesday said that Amphastar Pharmaceuticals Inc. cannot bring federal antitrust claims against Momenta Pharmaceuticals Inc. for allegedly suppressing competition of sales of a generic blood clot drug because its alleged injury stems from a prior court-issued injunction, immunizing Momenta from suit.